Background/Purpose: The Lipid Rich Plaque (LRP) study demonstrated the association between coronary plaque lipid content and outcomes. In this LRP substudy, we assessed the impact of optimal medical therapy (OMT) on the occurrence of non-culprit major adverse cardiac events (NC-MACE). Advanced intracoronary imaging modalities are able to identify patients with vulnerable coronary lesion morphology associated with future events. Methods/Materials: A total of 1270 patients who underwent cardiac catheterization for suspected coronary artery disease (CAD) with evaluable maxLCBI(4mm) in non-culprit vessels and known medical therapy after discharge were followed for 2 years. OMT was defined as the use of a statin and dual antiplatelet therapy (DAPT). Results: Among the 1270 patients included in this substudy, 1110 (87.7%) had PCI for an index event, and 1014 (80%) patients received OMT. Estimated cumulative incidence functions of NC-MACE did not differ significantly between patients treated with or without OMT (log-rank p-value = 0.876). In patients labeled high risk (maxLCBI(4mm)> 400), cumulative incidence function also did not differ between patients treated with vs without OMT (log-rank p-value = 0.19). Conclusions: In the current LRP analysis, we could not identify a beneficial effect of OMT in the reduction of NC MACE rate, even in patients with high-risk plaques, during 24-month follow-up.(C) 2021 Published by Elsevier Inc.
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and Statins / Renkens, Mick P L; Mintz, Gary S; Torguson, Rebecca; Di Mario, Carlo; Ten Cate, Tim; Ali, Ziad A; Singh, Varinder; Skinner, William; Artis, Andre; Garcia-Garcia, Hector M; de Winter, Robbert J; Wykrzykowska, Joanna J; Waksman, Ron. - In: CARDIOVASCULAR REVASCULARIZATION MEDICINE. - ISSN 1553-8389. - STAMPA. - 37:(2022), pp. 92-96. [10.1016/j.carrev.2021.07.015]
Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and Statins
Di Mario, Carlo;
2022
Abstract
Background/Purpose: The Lipid Rich Plaque (LRP) study demonstrated the association between coronary plaque lipid content and outcomes. In this LRP substudy, we assessed the impact of optimal medical therapy (OMT) on the occurrence of non-culprit major adverse cardiac events (NC-MACE). Advanced intracoronary imaging modalities are able to identify patients with vulnerable coronary lesion morphology associated with future events. Methods/Materials: A total of 1270 patients who underwent cardiac catheterization for suspected coronary artery disease (CAD) with evaluable maxLCBI(4mm) in non-culprit vessels and known medical therapy after discharge were followed for 2 years. OMT was defined as the use of a statin and dual antiplatelet therapy (DAPT). Results: Among the 1270 patients included in this substudy, 1110 (87.7%) had PCI for an index event, and 1014 (80%) patients received OMT. Estimated cumulative incidence functions of NC-MACE did not differ significantly between patients treated with or without OMT (log-rank p-value = 0.876). In patients labeled high risk (maxLCBI(4mm)> 400), cumulative incidence function also did not differ between patients treated with vs without OMT (log-rank p-value = 0.19). Conclusions: In the current LRP analysis, we could not identify a beneficial effect of OMT in the reduction of NC MACE rate, even in patients with high-risk plaques, during 24-month follow-up.(C) 2021 Published by Elsevier Inc.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1553838921005224-main.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
652.36 kB
Formato
Adobe PDF
|
652.36 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.